流行学与人群防治
ENGLISH ABSTRACT
中国≥40岁糖尿病患者的心血管疾病风险
李建新
李莹
刘芳超
陈纪春
曹杰
陈恕凤
胡东生
沈冲
黄建凤
鲁向锋
顾东风
作者及单位信息
·
DOI: 10.3760/cma.j.cn112148-20191203-00733
Cardiovascular disease risk in diabetes patients aged 40 years old and above in China
Li Jianxin
Li Ying
Liu Fangchao
Chen Jichun
Cao Jie
Chen Shufeng
Hu Dongsheng
Shen Chong
Huang Jianfeng
Lu Xiangfeng
Gu Dongfeng
Authors Info & Affiliations
Li Jianxin
Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
Li Ying
Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
Liu Fangchao
Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
Chen Jichun
Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
Cao Jie
Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
Chen Shufeng
Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
Hu Dongsheng
School of Public Health, Shenzhen University, Shenzhen 518060, China
Shen Chong
School of Public Health, Nanjing Medical University, Nanjing 211166, China
Huang Jianfeng
Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
Lu Xiangfeng
Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
Gu Dongfeng
Key Laboratory of Cardiovascular Epidemiology & Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
·
DOI: 10.3760/cma.j.cn112148-20191203-00733
2837
565
0
0
5
4
PDF下载
APP内阅读
摘要

目的评估我国40岁及以上糖尿病患者及其处于不同心血管疾病(CVD)发病风险时远期CVD发病率和缺血性、出血性心血管事件发生率。

方法本研究为前瞻性队列研究,研究对象来自中国动脉粥样硬化性心血管疾病风险预测研究(China-PAR),纳入全国15个省市40岁及以上人群,依据基线资料将调查对象分为糖尿病组和非糖尿病组;利用China-PAR模型计算研究对象10年CVD发病风险,以5%、10%为切点将研究对象分为低、中、高危。2007至2015年间对研究队列进行了2次随访,随访终点为CVD,包括非致死急性心肌梗死、冠心病死亡和卒中;按发病性质又进一步将终点事件分为缺血性和出血性心血管事件,其中缺血性事件包括非致死急性心肌梗死、冠心病死亡、非致死性和致死性缺血性卒中,出血性事件包括非致死性和致死性蛛网膜下腔出血和脑出血。比较糖尿病和非糖尿病人群及其在不同风险水平的CVD发病率及缺血性、出血性心血管事件发生率。

结果本研究共纳入40岁及以上人群89 209人,年龄(54.8±9.4)岁,其中男性36 794例(41.2%),平均随访时间8.5年。糖尿病组5 730例(6.4%)。≥40岁糖尿病患者中,10年CVD风险高危者占53.7%(3 075/5 730)。调整年龄、性别后,糖尿病患者CVD、缺血性和出血性心血管事件发生率(1 066.93/10万人年、824.23/10万人年和211.56/10万人年)低于CVD发病风险高危非糖尿病者(1 773.73/10万人年、1 228.18/10万人年和446.49/10万人年)( P均<0.001)。在CVD高危人群中,与非糖尿病者相比,糖尿病患者缺血性心血管事件发病率更高(1 638.47/10万人年比1 228.18/10万人年, P<0.001),而出血性心血管事件发病率偏低,但差异无统计学意义(415.70/10万人年比446.49/10万人年, P=0.635);在CVD低、中危人群中,两组的缺血性和出血性心血管事件发生率差异均无统计学意义( P均>0.05)。

结论我国40岁及以上糖尿病患者中,半数以上处于CVD发病风险高危水平;不同CVD发病风险水平的糖尿病患者,CVD、缺血性和出血性心血管事件发生率差别明显。

糖尿病;心血管病风险;发病率
ABSTRACT

ObjectiveTo evaluate the incidence of cardiovascular disease (CVD), ischemic and hemorrhagic cardiovascular events among Chinese diabetic patients aged 40 years and above with different CVD risk levels.

MethodsThis study enrolled participants aged 40 years and above in 15 provinces from a prospective cohort study, the China-PAR project (Prediction for Atherosclerotic Cardiovascular Disease Risk in China). Participants were categorized into two groups according to the presence or absence of diabetes at baseline. Individuals were further classified into low (0-4.9%), moderate (5%-9.9%) and high risk groups (≥10%), based on predicted ten-year CVD risk using the China-PAR equations. Two followed-up surveys were conducted between 2007 and 2015 to identify CVD events, which were defined as nonfatal acute myocardial infarction, or death due to coronary heart disease, or stroke. Ischemic cardiovascular events included nonfatal acute myocardial infarction, or death due to coronary heart disease, or ischemic stroke. Hemorrhagic cardiovascular events included subarachnoid hemorrhage and intracerebral hemorrhage. The incidences of CVD, ischemic and hemorrhagic cardiovascular events were compared in diabetes and non-diabetes population with different CVD risk levels.

ResultsThis study included 89 209 participants aged 40 years and above, the average follow-up period was 8.5 years. The age was (54.8±9.4) years, and 36 794 (41.2%) were men, and 5 730 (6.4%) were diabetic patients. In diabetes patients aged 40 years and above, 53.7% (3 075/5 730) were at high risk of CVD. Age-and sex-adjusted incidence of CVD, ischemic and hemorrhagic cardiovascular events (1 066.93/100 000 person-years, 824.23/100 000 person-years, and 211.56/100 000 person-years) were significantly lower in diabetes patients than those in non-diabetes population with high CVD risk (1 773.73/100 000 person-years, 1 228.18/100 000 person-years, and 446.49/100 000 person-years) (all P<0.001). Among high CVD risk populations, incidence of ischemic events was significantly higher in diabetic patients than in non-diabetes population (1 638.47/100 000 person-years vs. 1 228.18/100 000 person-years, P<0.001), but incidence of hemorrhagic events tended to be lower in diabetic patients than in non-diabetes population (415.70/100 000 person-years vs. 446.49/100 000 person-years, P=0.635). Incidence of ischemic and hemorrhagic events were similar between diabetes patients and non-diabetes population at low or moderate CVD risk groups (all P>0.05).

ConclusionsMore than half of diabetes patients aged 40 years and above in China have high CVD risk. The incidence of CVD, ischemic and hemorrhagic cardiovascular events are different in diabetic patients with different CVD risk levels.

Diabetes;Cardiovascular disease risk;Incidence
Lu Xiangfeng, Email: mocdef.aabnisulgnefgnaix
引用本文

李建新,李莹,刘芳超,等. 中国≥40岁糖尿病患者的心血管疾病风险[J]. 中华心血管病杂志,2020,48(11):968-974.

DOI:10.3760/cma.j.cn112148-20191203-00733

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
心血管疾病(cardiovascular disease,CVD)是造成全球死亡及疾病负担的首要原因 1 , 2。糖尿病是CVD的主要危险因素之一,2001年美国国家胆固醇教育计划第3次报告提出将糖尿病作为冠心病等危症 3。但随后研究结果表明并非所有的糖尿病患者都有相同的CVD发病风险,其风险还受到性别、年龄、糖尿病病情和病程以及并存的其他CVD危险因素的影响 4 , 5 , 6 , 7。近期美国血脂指南和CVD一级预防指南均指出,40~75岁糖尿病患者的CVD发病风险多处于中高危水平,对糖尿病患者进行CVD发病风险评估有利于使治疗决策的制定精准化 8 , 9。《中国心血管病预防指南(2017)》提出,≥40岁的糖尿病患者是CVD高危人群 10,但是其CVD发病风险处于何种水平,目前尚缺乏国内研究资料。本研究通过分析我国大型前瞻性队列研究——中国动脉粥样硬化性心血管疾病风险预测研究(Prediction for Atherosclerotic Cardiovascular Disease Risk in China,China-PAR)的随访数据,对比了糖尿病及非糖尿病患者的CVD、缺血性和出血性事件发生率,并依据10年CVD发病风险对其进行分层,旨在明确我国糖尿病患者的CVD发病风险,为指南的制定提供循证医学证据。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
1
GBD Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018,392(10159):1736-1788. DOI: 10.1016/S0140-6736(18)32203-7 .
返回引文位置Google Scholar
百度学术
万方数据
2
Zhou M , Wang H , Zeng X ,et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019,394(10204):1145-1158. DOI: 10.1016/S0140-6736(19)30427-1 .
返回引文位置Google Scholar
百度学术
万方数据
3
Expert Panel on Detection,Evaluation, andTreatment of High Blood Cholesterol in Adults. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel Ⅲ)[J]. JAMA, 2001,285(19):2486-2497. DOI: 10.1001/jama.285.19.2486.PMID:11368702 .
返回引文位置Google Scholar
百度学术
万方数据
4
Howard BV , Best LG , Galloway JM ,et al. Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors[J]. Diabetes Care, 2006,29(2):391-397. DOI: 10.2337/diacare.29.02.06.dc05-1299 .
返回引文位置Google Scholar
百度学术
万方数据
5
Bulugahapitiya U , Siyambalapitiya S , Sithole J ,et al. Is diabetes a coronary risk equivalent? Systematic review and meta-analysis[J]. Diabet Med, 2009,26(2):142-148. DOI: 10.1111/j.1464-5491.2008.02640.x .
返回引文位置Google Scholar
百度学术
万方数据
6
Mondesir FL , Brown TM , Muntner P ,et al. Diabetes, diabetes severity, and coronary heart disease risk equivalence: REasons for Geographic and Racial Differences in Stroke (REGARDS)[J]. Am Heart J, 2016,181:43-51. DOI: 10.1016/j.ahj.2016.08.002 .
返回引文位置Google Scholar
百度学术
万方数据
7
Rana JS , Liu JY , Moffet HH ,et al. Diabetes and prior coronary heart disease are not necessarily risk equivalent for future coronary heart disease events[J]. J Gen Intern Med, 2016,31(4):387-393. DOI: 10.1007/s11606-015-3556-3 .
返回引文位置Google Scholar
百度学术
万方数据
8
Grundy SM , Stone NJ , Bailey AL ,et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J]. Circulation, 2019,139(25):e1082-1082e1143. DOI: 10.1161/CIR.0000000000000625 .
返回引文位置Google Scholar
百度学术
万方数据
9
Arnett DK , Blumenthal RS , Albert MA ,et al. 2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J]. J Am Coll Cardiol, 2019,74(10):e177-177e232. DOI: 10.1016/j.jacc.2019.03.010 .
返回引文位置Google Scholar
百度学术
万方数据
10
中国心血管病预防指南(2017)写作组,中华心血管病杂志编辑委员会. 中国心血管病预防指南(2017)[J]. 中华心血管病杂志,, 2018(46):1-10. 25DOI: 10.3760/cma.j.issn.0253-3758.2018.01.004 .
返回引文位置Google Scholar
百度学术
万方数据
11
Yang X , Li J , Hu D ,et al. Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: the China-PAR project (Prediction for ASCVD Risk in China)[J]. Circulation, 2016,134(19):1430-1440. DOI: 10.1161/CIRCULATIONAHA.116.022367 .
返回引文位置Google Scholar
百度学术
万方数据
12
Yang XL , Chen JC , Li JX ,et al. Risk stratification of atherosclerotic cardiovascular disease in Chinese adults[J]. Chronic Dis Transl Med, 2016,2(2):102-109. DOI: 10.1016/j.cdtm.2016.10.001 .
返回引文位置Google Scholar
百度学术
万方数据
13
中国心血管病风险评估和管理指南编写联合委员会. 中国心血管病风险评估和管理指南[J]. 中华预防医学杂志, 2019,53(1):13-35. DOI: 10.3760/cma.j.issn.0253-9624.2019.01.004 .
返回引文位置Google Scholar
百度学术
万方数据
14
Zhao D . Poisson regression adjustment of event rates and its macro procedure ADJ_POIS[C].// SAS Users Group 24th International Annual Conference, 1999,Miami Beach,Florida.
返回引文位置Google Scholar
百度学术
万方数据
15
Fine JP , Gray RJ . A proportional hazards model for the subdistribution of a competing risk[J]. J Am Stat Assoc, 1999,94(446):496-509.
返回引文位置Google Scholar
百度学术
万方数据
16
中国成人血脂异常防治指南修订联合委员会. 中国成人血脂异常防治指南(2016年修订版)[J]. 中华心血管病杂志, 2016,44(10):833-853. DOI: 10.3760/cma.j.issn.0253-3758.2016.10.005 .
返回引文位置Google Scholar
百度学术
万方数据
17
Wong ND , Glovaci D , Wong K ,et al. Global cardiovascular disease risk assessment in United States adults with diabetes[J]. Diab Vasc Dis Res, 2012,9(2):146-152. DOI: 10.1177/1479164112436403 .
返回引文位置Google Scholar
百度学术
万方数据
18
陈一佳,苏健,覃玉,. 江苏省两城市35岁及以上2型糖尿病患者缺血性心血管病10年发病风险评估[J]. 中华预防医学杂志, 2019,53(2):218-222. DOI: 10.3760/cma.j.issn.0253?9624.2019.02.018 .
返回引文位置Google Scholar
百度学术
万方数据
19
Bragg F , Holmes MV , Iona A ,et al. Association between diabetes and cause-specific mortality in rural and urban areas of China[J]. JAMA, 2017,317(3):280-289. DOI: 10.1001/jama.2016.19720 .
返回引文位置Google Scholar
百度学术
万方数据
20
Shah AD , Langenberg C , Rapsomaniki E ,et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people[J]. Lancet Diabetes Endocrinol, 2015,3(2):105-113. DOI: 10.1016/S2213-8587(14)70219-0 .
返回引文位置Google Scholar
百度学术
万方数据
21
Kuusisto J , Laakso M . Update on type 2 diabetes as a cardiovascular disease risk equivalent[J]. Curr Cardiol Rep, 2013,15(2):331. DOI: 10.1007/s11886-012-0331-5 .
返回引文位置Google Scholar
百度学术
万方数据
22
Zheng SL , Roddick AJ . Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis[J]. JAMA, 2019,321(3):277-287. DOI: 10.1001/jama.2018.20578 .
返回引文位置Google Scholar
百度学术
万方数据
23
Abdelaziz HK , Saad M , Pothineni N ,et al. Aspirin for primary prevention of cardiovascular events[J]. J Am Coll Cardiol, 2019,73(23):2915-2929. DOI: 10.1016/j.jacc.2019.03.501 .
返回引文位置Google Scholar
百度学术
万方数据
24
中华医学会老年医学分会,《中华内科杂志》编辑委员会《中华老年医学杂志》编辑委员会. 阿司匹林在动脉粥样硬化性心血管疾病中的临床应用:中国专家共识(2016)[J]. 中华内科杂志, 2017,56(1):68-80. DOI: 10.3760/cma.j.issn.0578-1426.2017.01.020 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
鲁向锋,Email: mocdef.aabnisulgnefgnaix
B

李建新, 李莹, 刘芳超, 等. 中国≥40岁糖尿病患者的心血管疾病风险[J]. 中华心血管病杂志, 2020, 48(11): 968-974. DOI: 10.3760/cma.j.cn112148-20191203-00733.

C
所有作者均声明不存在利益冲突
D
中国医学科学院医学与健康科技创新工程 (2017-I2M-1-004,2019-I2M-2-003)
国家重点研究计划 (2017YFC0211700,2016YFC0206503,2018YFC1311703)
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号